Next-Generation Sequencing of DDX41 in Myeloid Neoplasms Leads to Increased Detection of Germline Alterations
暂无分享,去创建一个
K. Bhalla | H. Kantarjian | G. Garcia-Manero | M. Routbort | K. Patel | T. Kadia | F. Ravandi | Koichi Takahashi | G. Borthakur | N. Daver | C. Dinardo | J. Khoury | N. Pemmaraju | R. Mehta | B. Oran | Y. Alvarado | K. Sasaki | Sarah Bannon | G. Montalban-Bravo | K. Naqvi | F. Jelloul | R. K. Shamanna | Richard Champlin | G. Issa | M. Konopleva
[1] K. Bhalla,et al. Successful lenalidomide treatment in high risk myelodysplastic syndrome with germline DDX41 mutation , 2020, American journal of hematology.
[2] J. Soulier,et al. Germline DDX41 mutations define a significant entity within adult MDS/AML patients. , 2019, Blood.
[3] H. Kantarjian,et al. DDX41 mutations in myeloid neoplasms are associated with male gender, TP53 mutations and high‐risk disease , 2019, American journal of hematology.
[4] F. Meric-Bernstam,et al. Improving the detection of patients with inherited predispositions to hematologic malignancies using next‐generation sequencing‐based leukemia prognostication panels , 2018, Cancer.
[5] Sushant A. Patil,et al. Prognostic tumor sequencing panels frequently identify germ line variants associated with hereditary hematopoietic malignancies. , 2018, Blood advances.
[6] Anna L. Brown,et al. Myeloid neoplasms with germline DDX41 mutation , 2017, International Journal of Hematology.
[7] Anna L. Brown,et al. DDX41-related myeloid neoplasia. , 2017, Seminars in hematology.
[8] H. Harada,et al. Donor cell leukemia arising from preleukemic clones with a novel germline DDX41 mutation after allogenic hematopoietic stem cell transplantation , 2017, Leukemia.
[9] R. Sinke,et al. Re-emergence of acute myeloid leukemia in donor cells following allogeneic transplantation in a family with a germline DDX41 mutation , 2017, Leukemia.
[10] N. Young,et al. Clinical utility of gene panel-based testing for hereditary myelodysplastic syndrome/acute leukemia predisposition syndromes , 2017, Leukemia.
[11] J. Orange,et al. Evaluation of Patients and Families With Concern for Predispositions to Hematologic Malignancies Within the Hereditary Hematologic Malignancy Clinic (HHMC). , 2016, Clinical lymphoma, myeloma & leukemia.
[12] Mario Cazzola,et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. , 2016, Blood.
[13] T. Olson,et al. Genetic predisposition to myelodysplastic syndrome and acute myeloid leukemia in children and young adults , 2016, Leukemia & lymphoma.
[14] Anna L. Brown,et al. Novel germ line DDX41 mutations define families with a lower age of MDS/AML onset and lymphoid malignancies. , 2016, Blood.
[15] Christopher A. Miller,et al. Genomic analysis of germ line and somatic variants in familial myelodysplasia/acute myeloid leukemia. , 2015, Blood.
[16] S. Miyano,et al. Inherited and Somatic Defects in DDX41 in Myeloid Neoplasms. , 2015, Cancer cell.
[17] D. Babushok,et al. Genetic predisposition syndromes: when should they be considered in the work-up of MDS? , 2015, Best practice & research. Clinical haematology.
[18] O. Olopade,et al. Proposal for the clinical detection and management of patients and their family members with familial myelodysplastic syndrome/acute leukemia predisposition syndromes , 2013, Leukemia & lymphoma.
[19] Yong‐jun Liu,et al. The helicase DDX41 senses intracellular DNA mediated by the adaptor STING in dendritic cells , 2011, Nature Immunology.